Ferruccio Bonino researcher
Bonino, Ferruccio.
VIAF ID: 156691202 (Personal)
Permalink: http://viaf.org/viaf/156691202
Preferred Forms
- 100 1 _ ‡a Bonino, Ferruccio
-
- 100 0 _ ‡a Ferruccio Bonino ‡c researcher
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Effects of a bicarbonate-alkaline mineral water on gastric functions and functional dyspepsia: a preclinical and clinical study. | |
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment | |
The epidemiology of hepatitis delta infection in Italy. Promoting Group | |
Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections | |
Foreword | |
From actors to authors: a first account about the involvement of patients in the informed consent governance of a major Italian translational research hospital | |
Genome-Wide Comparison of Next-Generation Sequencing and qPCR Platforms for microRNA Profiling in Serum | |
HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial | |
Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. | |
Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. | |
Hepatitis B virus heterogeneity, one of many factors influencing the severity of hepatitis B. | |
Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. | |
Hepatitis C virus infection and liver disease: peculiar epidemiological and clinicopathological features | |
Hepatitis delta virus, a model of liver cell pathology. | |
Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease? [corrected] | |
High prevalence of G1 and G2 TT-virus infection in subjects with high and low blood exposure risk: identification of G4 isolates in Italy. | |
Horse antilymphocytic globulin in hepatitis B exacerbation after bone marrow transplantation adoptive immunity transfer. | |
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis | |
Immunohistochemical research on HDV infection in Chinese patients with chronic liver disease | |
The immunological diagnosis of HBsAg liver disease by combined screening for the e system in the serum and the HB core and surface antigens in liver biopsy samples | |
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient | |
The impact of molecular biology in the diagnosis and management of viral hepatitis | |
Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection | |
The importance of hepatitis B viral DNA in serum and liver | |
Incidence and Significance of Different Types of Connective Tissue Antibodies in Adult and Pediatric Gastroenterological Disorders | |
Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin. | |
Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein | |
Introduction to 'Hepatitis B virus heterogeneity--a means to personalized care'. | |
Is high AgNOR quantity in hepatocytes associated with increased risk of hepatocellular carcinoma in chronic liver disease? | |
Liver transplantation in genetic defects of hepatocytes | |
Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance | |
Molecular analysis of VHI+ B lymphocytes in hepatitis C patients | |
Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc | |
Multicenter evaluation of the Elecsys hepatitis B surface antigen quantitative assay. | |
New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases | |
A novel method for banking dental pulp stem cells. | |
Nucleic acid hybridization in viral hepatitis research. | |
Optimization of in vitro HBV replication and HBsAg production in HuH7 cell line. | |
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study | |
Pathophysiology of Non Alcoholic Fatty Liver Disease | |
Precore mutant hepatitis B virus and outcome of chronic infection and hepatitis in hepatitis B e antigen-positive children. | |
Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B | |
Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy | |
Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon C.H.S.G. | |
The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease | |
Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination. | |
Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new “gray-zone” for the evaluation of “borderline” values | |
Quantitative analysis of wild-type and HBeAg minus hepatitis B viruses by a sequence-dependent primer extension assay | |
Reduced expression of the melanocortin-1 receptor in human liver during brain death. | |
Replicating and virion secreting hepatitis B mutant virus unable to produce preS2 protein | |
Reply to: "To target or not to target viral antigens in HBV related HCC?". | |
Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotype | |
Riboprobe assay for HDV RNA: a sensitive method for the detection of the HDV genome in clinical serum samples. | |
Role of hepatitis delta virus infection in hepatocellular carcinoma. | |
Safety of anti-HCV-reactive immunoglobulin in heart transplant patients | |
Sequence variation in hepatitis C viral isolates. | |
A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection. | |
Severe liver disease is caused by HBV rather than HCV in children with hematological malignancies | |
Software and expert system for the management of chronic hepatitis B. | |
A solid-phase enzyme immunoassay (EIA) for detection of HBeAg and anti-HBe | |
The spectrum of complement-fixing antinuclear antibodies in patients with hepatocellular carcinoma. | |
Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders. | |
T cell receptor-therapy in HBV-related hepatocellularcarcinoma | |
Thermal care of functional dyspepsia based on bicarbonate-sulphate-calcium water: a sequential clinical trial. | |
Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease. | |
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases | |
Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate. | |
Treatment with interferon of chronic hepatitis B associated with antibody to hepatitis B e antigen | |
Usefulness of IgM anti-HCV in differential diagnosis between recurrent hepatitis C and acute rejection in liver transplant patients | |
Validation and comparison of different PCR-based methods for detection of hepatitis B virus precore region mutants. | |
Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins | |
Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C | |
মুখবন্ধ |